Ceftazidime-Avibactam PK/PD and Resistance in Hematology Patients

NCT07703644 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Hematologic Neoplasms
Gram-Negative Bacterial Infections
Pseudomonas Aeruginosa Infection
Klebsiella Pneumoniae Infections
Drug Resistance, Bacterial

Interventions

DRUG: Ceftazidime-avibactam
PROCEDURE: Therapeutic Drug Monitoring (TDM) and Microbiological Surveillance

Sponsor

Sizhou Feng